Nasal Immunization with a Recombinant HIV gp120 and Nanoemulsion Adjuvant Produces Th1 Polarized Responses and Neutralizing Antibodies to Primary HIV Type 1 Isolates-Reference-Cited by-同舟云学术

Nasal Immunization with a Recombinant HIV gp120 and Nanoemulsion Adjuvant Produces Th1 Polarized Responses and Neutralizing Antibodies to Primary HIV Type 1 Isolates

Published:2008-02 Issue:2 Volume:24 Page:271-281
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Bielinska Anna U.¹,Janczak Katarzyna W.¹,Landers Jeffrey J.¹,Markovitz David M.²,Montefiori David C.³,Baker James R.¹

Affiliation:

1. Michigan Nanotechnology Institute for Medicine and Biological Sciences (MNIMBS), University of Michigan, Ann Arbor, Michigan 48109.

2. Internal Medicine, Infectious Diseases, University of Michigan, Ann Arbor, Michigan 48109.

3. Department of Surgery, Laboratory for AIDS Vaccine Research and Development, Duke University Medical Center, Durham, North Carolina 27706.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2007.0148

Reference82 articles.

1. A vaccine for HIV type 1: The antibody perspective

2. HIV vaccine design and the neutralizing antibody problem

3. Progress and obstacles in the development of an AIDS vaccine

4. Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency Virus

5. The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoemulsions a Delivery System in the Making for Tumor Targeting Therapeutics: Evaluation and Characterization to Meet Clinical Challenges;Current Pharmaceutical Biotechnology;2024-04-02

2. Nano Emulsions: A Novel Targeted Delivery of Cancer Therapeutics;Nanoemulsions - Design and Applications [Working Title];2024-03-26

3. Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice;npj Vaccines;2023-06-29

4. Nanomaterial-based delivery of vaccine through nasal route: Opportunities, challenges, advantages, and limitations;Journal of Drug Delivery Science and Technology;2022-08

5. LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives;Current Opinion in Allergy & Clinical Immunology;2022-07-02